Low-dose oral contraception and bone density;Niedrig dosierte orale kontrazeptiva und knochendichte

Therapeutische Umschau

Volumn 58, Issue 9, 2001, Pages 547-551

  Karck, Ulrich ^a   Breckwoldt, M ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ESTRADIOL; ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; VITAMIN D;

BONE DENSITY; BONE DISEASE; BONE MASS; BONE METABOLISM; BONE REMODELING; CALCIUM INTAKE; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; MENOPAUSE; ORAL CONTRACEPTION; PHYSICAL ACTIVITY; RELIABILITY; REVIEW; RISK ASSESSMENT; VITAMIN SUPPLEMENTATION;

EID: 0034850148     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.58.9.547     Document Type: Review

References (20)

1. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nature Medicine 1996; 2 (10): 1132-6.
2. Hartard M, Bottermann P, Bartenstein P, Jeschke D. Schwaiger M. Effects on bone mineral density of lowdosed oral contraceptives compared to and combined with physical activity. Contraception 1997; 55 (2): 87-90.
3. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology & Metabolism 1991; 73 (3): 555-63.
4. Theintz G, Buchs B, Rizzoli R et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. Journal of Clinical Endocrinology & Metabolism 1992; 75(4): 1060-5.
5. Teegarden D, Proulx WR, Martin BR, et al. Peak bone mass in young women. Journal of Bone & Mineral Research 1995; 10 (5): 711-5.
6. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA 1992; 268(17): 2403-8.
7. Vessey M, Mant J, Painter R. Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study. Contraception 1998; 57 (4): 231-5.
8. Pasco JA, Kotowicz MA, Henry MJ, Panahi S, Seeman E, Nicholson GC. Oral contraceptives and bone mineral density: A population-based study. American Journal of Obstetrics & Gynecology 2000; 182 (2): 265-9.
9. MacDougall J, Davies MC, Overton CE et al. Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women. British Journal of Family Planning 1999; 25 (3): 96-100.
10. Masaryk P, Lunt M, Benevolenskaya L et al. Effects of menstrual history and use of medications on bone mineral density: the EVOS Study. Calcified Tissue International 1998; 63 (4): 271-6.
11. Petitti DB, Piaggio G, Mehta S, Cravioto MC, Meirik O. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstetrics & Gynecology 2000; 95 (5): 736-44.
12. Kleerekoper M, Brienza RS, Schultz LR, Johnson CC. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Archives of Internal Medicine 1991; 151 (10): 1971-6.
13. Kuohung W, Borgatta L, Stubblefield P. Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. [Review] [39 refs] Contraception 2000; 61 (2): 77-82.
14. Volpe A, Amram A, Cagnacci A, Battaglia C. Biochemical aspects of hormonal contraception: effects on bone metabolism. European Journal of Contraception & Reproductive Health Care 1997; 2 (2): 123-6.
15. Garnero P, Sornay-Rendu E, Delmas PD. Decreased bone turnover in oral contraceptive users. Bone 1995; 16 (5): 499-503.
16. Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Genazzani AR. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Osteoporosis International 2000; 11 (6): 544-8.
17. Paoletti AM, Orru M, Floris S, et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception 2000; 61 (4): 259-63.
18. Mais V, Fruzzetti F, Ajossa S, Paoletti AM, Guerriero S, Melis GB. Bone metabolism in young women taking a monophasic pill containing 20 meg ethinylestradiol: a prospective study. Contraception 1993; 48 (5): 445-52.
19. Polatti F, Perotti F, Filippa N, Gallina D, Nappi RE. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 1995; 51 (4): 221-4.
20. Rice CF, Killick SR, Dieben T, Coelingh Bennink H. A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily. Human Reproduction 1999; 14 (4): 982-5.